Empowered Funds
PLRX icon

Empowered Funds’s Pliant Therapeutics PLRX Stock Holding History

Empowered Funds’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$87.4K Buy
+80,893
New +$89.7K ﹤0.01% 2430

Other funds holding PLRX

Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Monaco Asset Management
Monaco Asset Management Monaco $818M AUM 32.61% 1-Year Est. Return
Prosight Management
Prosight Management Dallas, Texas $515M AUM 2.95% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $188M AUM 88.51% 1-Year Est. Return
Peapod Lane Capital
Peapod Lane Capital Bedford Hills, New York $134M AUM 63.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Empowered Funds's PLRX Position: Q3 2026 in Review

Empowered Funds opened a new position in Pliant Therapeutics (PLRX) in Q3 2026: 80,893 shares worth $87.4K. The stake represents ﹤0.01% of the portfolio and ranks #2430 among its holdings.

49 funds tracked by Wall St. Rank hold PLRX as of Q3 2026.

  • Empowered Funds held 80,893 shares of Pliant Therapeutics worth $87.4K as of Q3 2026.
  • Pliant Therapeutics was a new Empowered Funds position in Q3 2026.
  • Pliant Therapeutics made up ﹤0.01% of Empowered Funds's portfolio in Q3 2026, its #2430 holding.
  • 49 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q3 2026.

Based on Empowered Funds's 13F filing for Q3 2026, filed 13 Nov 2026.